CXCL9 and neoplasm: Using a similar model, a more recent preclinical study reported that administration of Lm-LLO-E7 increases the secretion of chemokine (C-X-C motif) ligand 9 (CXCL9) by TC1 tumor cells and mediated the intratumoral infiltration of CD8+ T cells [39].